Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology

PDF) Recent advances in graves ophthalmopathy medical therapy: a

PDF) The Role of Oxidative Stress and Therapeutic Potential of

Rosuvastatin in the Primary Prevention of Cardiovascular Disease

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label

PDF) Traditional Chinese medicine in thyroid-associated orbitopathy

Statin use associated with lower incidence of developing thyroid

PDF) Management of Thyroid Eye Disease: A Consensus Statement by

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label

The effects of lowering LDL cholesterol with simvastatin plus